Dean's Fourth Annual Symposium on Entrepreneurship and Academic Drug Development

This symposium is designed for faculty, trainees, and students interested in advancing their research from the lab to the clinic. Learn about ways to partner with industry and the resources available at BioPharma Alliances and Research Collaborations, the Tri-Institutional Therapeutics Discovery Institute, Bridge Medicines, and the Center for Technology Licensing. Keynote Address by: John Maraganore, PhD Chief Executive Officer Alnylam Pharmaceuticals Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines. Featured Speakers: John P. Leonard, MD Senior Associate Dean for Innovation and Initiatives Richard T. Silver Distinguished Professor of Hematology and Medical Oncology Weill Cornell Medicine "Updates on Weill Cornell Medicine's Innovation Ecosystem" and Li Gan, PhD Director, Helen and Robert Appel Alzheimer’s Disease Research Institute Burton P. and Judith B. Resnick Distinguished Professor in Neurodegenerative Diseases, Feil Family Brain and Mind Research Institute Weill Cornell Medicine "Developing New Therapeutics for Neurodegenerative Disease"